Debates and conversations about timely topics in autism.
The preliminary success of a therapy designed to help infants with symptoms of autism raises broader questions about the potential promise and many challenges of early intervention.
New estimates on the role of common mutations in autism raise questions about how to quantify and parse genetic risk. Three experts say both common and rare variants are worth pursuing.
Reports of a century-old drug that reverses autism-like symptoms in mice raise key questions about the complexity of translating promising research into real treatments.
If inherited risk for autism is 50 percent, does that make the remaining half of risk environmental? Scientists clarify a large population study.
Disorganized patches found in the brains of children with autism prompt debate about their significance for the disorder. Three experts give their perspectives.
Do genetic differences or diagnostic biases account for the gender imbalance in autism? Catherine Lord, David Skuse and Angelica Ronald weigh in.
What evidence supports the idea that autism stems from overactive brain responses to sensory input? Researchers weigh in on this controversial theory.
A new research network aims to study autism’s least-understood population: those with the most severe forms of the disorder. Three experts weigh in on the project’s potential impact.
